| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |